Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
PostTraumatic Stress Disorder
Interventions
DRUG

Placebo Oral Capsule

Placebo is administered only once (approximately 120 min prior to MR scanning in Visit 3) by the oral route and contains only dextrose in opaque capsules.

DRUG

Dronabinol Cap 5 milligrams (MG)

Dronabinol (5mg) is administered only once (approximately 120 min prior to MR scanning in Visit 3) by the oral route and is placed in an opaque capsule with dextrose filler.

DRUG

Dronabinol Cap 10 milligrams (MG)

Dronabinol (10mg) is administered only once (approximately 120 min prior to MR scanning in Visit 3) by the oral route and is placed in an opaque capsule with dextrose filler.

Trial Locations (1)

48201

Eugene Applebaum College of Pharmacy and Health Sciences, Detroit

All Listed Sponsors
lead

Wayne State University

OTHER

NCT03008005 - Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study | Biotech Hunter | Biotech Hunter